Zhang Wei-Jie, Zhou Zhi-Hua, Guo Ming, Yang Liu-Qing, Xu Yuan-Yuan, Pang Tao-Hong, Gao Shan-Ting, Xu Xin-Yun, Sun Qi, Feng Min, Wang Hao, Lu Chun-Lei, Wu Guo-Zhong, Guan Wen-Xian, Xu Gui-Fang
Department of General Surgery, Drum Tower Clinical College of Nanjing Medical University, Nanjing, Jiangsu Province, China;; Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.
Department of Pathology, 101th Hospital of PLA, Wuxi, Jiangsu Providence, China.
J Cancer. 2017 Feb 10;8(3):363-370. doi: 10.7150/jca.16730. eCollection 2017.
As the most predominant tumor-infiltrating immune cells, tumor-associated macrophages (TAMs) are associated with poor outcome in multiple solid cancers and play important roles in cancer progression. Cancer stem cells (CSCs) may account for metastasis and recurrence after cancer therapy. However, the association between TAMs and CSCs is not clarified in gastric cancer (GC). The aim of the present study was to evaluate the effects of TAMs on CSCs in GC and find out the risk factors to predict recurrence and prognosis. This study included consecutive 236 patients with histologically confirmed primary GC. TAMs marker CD163 and CSCs-related proteins were detected by immunohistochemistry (IHC) in GC tissues and their prognostic values were all investigated. High expression of CD163 TAMs was found in patents with aggressive characteristics, especially for patents with recurrence. There existed a significant correlation between high expression of CD163 and CSCs-related markers in GC tissues. In patients with recurrence, high-expression of CD163 TAMs was an independent worse prognostic factor. High infiltration of TAMs was related to aggressive behavior, associated with aberrant expression of CSC markers, and an independent worse prognostic factor in GC. Targeting TAMs may be a potential treatment strategy for GC, including patients with recurrence.
作为最主要的肿瘤浸润免疫细胞,肿瘤相关巨噬细胞(TAMs)与多种实体癌的不良预后相关,并在癌症进展中发挥重要作用。癌症干细胞(CSCs)可能是癌症治疗后转移和复发的原因。然而,在胃癌(GC)中,TAMs与CSCs之间的关联尚不清楚。本研究的目的是评估TAMs对GC中CSCs的影响,并找出预测复发和预后的危险因素。本研究纳入了连续236例经组织学确诊的原发性GC患者。通过免疫组织化学(IHC)检测GC组织中TAMs标志物CD163和CSCs相关蛋白,并研究它们的预后价值。在具有侵袭性特征的患者中发现CD163 TAMs高表达,尤其是复发患者。GC组织中CD163高表达与CSCs相关标志物之间存在显著相关性。在复发患者中,CD163 TAMs高表达是一个独立的不良预后因素。TAMs的高浸润与侵袭性行为有关,与CSC标志物的异常表达相关,并且是GC中一个独立的不良预后因素。靶向TAMs可能是GC的一种潜在治疗策略,包括复发患者。